Skip to main content

Table 2 Association testing of PARP-1 polymorphisms with risk of NHL

From: PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males

NPs Genotype Controls
no.(%)
Cases
no.(%)
OR (95% CI)
Asp81Asp GG 227 (31.5) 185 (32.5) 1
  GA 349 (48.4) 279 (49.0) 0.99 (0.77-1.27)
  AA 145 (20.1) 105 (18.5) 0.90 (0.65-1.24)
  GA+AA 494 (68.5) 384 (67.5) 0.96 (0.76-1.21)
Ala284Ala CC 424 (58.8) 357 (62.4) 1
  CT 264 (36.6) 189 (33.0) 0.85 (0.67-1.07)
  TT 33 (4.6) 26 (4.5) 0.94 (0.55-1.60)
  CT+TT 297 (41.2) 215 (37.6) 0.86 (0.69-1.08)
Lys352Lys GG 222 (30.8) 184 (32.1) 1
  GA 353 (49.0) 285 (49.7) 0.98 (0.76-1.26)
  AA 145 (20.1) 104 (18.2) 0.87 (0.64-1.20)
  GA+AA 498 (69.2) 389 (67.9) 0.95 (0.75-1.20)
IVS13+118 A>G AA 426 (59.2) 361 (63.0) 1
  AG 261 (36.3) 188 (32.8) 0.85 (0.67-1.07)
  GG 33 (4.6) 24 (4.2) 0.86 (0.50-1.48)
  AG+GG 294 (40.8) 212 (37.0) 0.85 (0.68-1.06)
Val762Ala TT 221 (30.7) 189 (33.0) 1
  TC 354 (49.1) 279 (48.7) 0.93 (0.72-1.19)
  CC 146 (20.2) 105 (18.3) 0.85 (0.62-1.17)
  TC+CC 500 (69.3) 384 (67.0) 0.90 (0.71-1.14)
  1. All analyses have been age- and sex-adjusted. P values were > 0.05 in all analyses.